Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 06-1998 | 12-1997 | 06-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,790 | -9,790 | -9,200 | -9,200 | N/A |
| Depreciation Amortization | 3,270 | 3,270 | 2,500 | 2,500 | N/A |
| Other Working Capital | -560 | -560 | 7 | 7 | N/A |
| Other Operating Activity | 60 | 60 | 113 | 113 | 0 |
| Operating Cash Flow | $-7,020 | $-7,020 | $-6,580 | $-6,580 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,180 | -3,180 | -4,650 | -4,650 | N/A |
| Other Investing Activity | 500 | 500 | 9,380 | 9,380 | 0 |
| Investing Cash Flow | $-2,680 | $-2,680 | $4,730 | $4,730 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 230 | 230 | 4,280 | 4,280 | 0 |
| Financing Cash Flow | $230 | $230 | $4,280 | $4,280 | $N/A |
| Beginning Cash Position | 24,070 | 24,070 | 13,230 | 13,230 | N/A |
| End Cash Position | 14,590 | 14,590 | 15,670 | 15,670 | N/A |
| Net Cash Flow | $-9,480 | $-9,480 | $2,440 | $2,440 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,020 | -7,020 | -6,580 | -6,580 | N/A |
| Free Cash Flow | -7,020 | -7,020 | -6,580 | -6,580 | 0 |